Heather N. Tinsley - Concepedia

Author

Heather N. Tinsley

Also Known As

H. N. Tinsley, H. Tinsley, Heather N. Tinsley, Heather Nicole Tinsley, Heather Tinsley, Hethar N. Tinsley, Tinsley Heather N

Publications

1.6K

Citations

H-Index

Concepts

All Affiliations

Southern Research Institute German University in Cairo University of Alabama at Birmingham University of South Alabama USA Mitchell Cancer Institute

About

Heather N. Tinsley is an author at Southern Research Institute specializing in medicine, drug discovery, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	566
2	Biochemistry	7	7	331
3	Natural Sciences	6	6	232
4	Engineering	1	1	20
5	Biomolecular Engineering	1	1	20

Heather N. Tinsley

Publications

1.4K

Citations

H-Index

Page 1

	Year	Citations
The Role of Cyclic Nucleotide Signaling Pathways in Cancer: Targets for Prevention and Treatment Alexandra M. Fajardo, Gary A. Piazza, Heather N. Tinsley Cancers	2014	212
Sulindac Selectively Inhibits Colon Tumor Cell Growth by Activating the cGMP/PKG Pathway to Suppress Wnt/β-Catenin Signaling Nan Li, Yaguang Xi, Heather N. Tinsley, Molecular Cancer Therapeutics	2013	133
Chronic Exposure to a High-Fat Diet Induces Hepatic Steatosis, Impairs Nitric Oxide Bioavailability, and Modifies the Mitochondrial Proteome in Mice Heather B. Eccleston, Kelly K. Andringa, Angela M. Betancourt, Antioxidants and Redox Signaling	2010	128
Inhibition of PDE5 by Sulindac Sulfide Selectively Induces Apoptosis and Attenuates Oncogenic Wnt/β-Catenin–Mediated Transcription in Human Breast Tumor Cells Heather N. Tinsley, Bernard D. Gary, Adam B. Keeton, Cancer Prevention Research	2011	111
Suppression of Wnt/β-catenin signaling inhibits prostate cancer cell proliferation Wenyan Lü, Heather N. Tinsley, Adam B. Keeton, European Journal of Pharmacology UrologySignaling PathwayCancer Cell BiologyTumor SuppressorProstatic Disease	2008	104
Sulindac sulfide selectively inhibits growth and induces apoptosis of human breast tumor cells by phosphodiesterase 5 inhibition, elevation of cyclic GMP, and activation of protein kinase G Heather N. Tinsley, Bernard D. Gary, Adam B. Keeton, Molecular Cancer Therapeutics Cgmp Pde InhibitorsBreast OncologyChemoprevention StrategyApoptosisCell Death	2009	99
A Novel Sulindac Derivative That Does Not Inhibit Cyclooxygenases but Potently Inhibits Colon Tumor Cell Growth and Induces Apoptosis with Antitumor Activity Gary A. Piazza, Adam B. Keeton, Heather N. Tinsley, Cancer Prevention Research	2009	97
Design, synthesis and biological evaluation of novel pyridine derivatives as anticancer agents and phosphodiesterase 3 inhibitors Tamer M. Ibrahim, Khaled A. M. Abouzid, Jochen Lehmann, Bioorganic & Medicinal Chemistry Medicinal ChemistryBiochemistryMedicineNatural SciencesPharmacological Agent	2009	94
Colon Tumor Cell Growth–Inhibitory Activity of Sulindac Sulfide and Other Nonsteroidal Anti-Inflammatory Drugs Is Associated with Phosphodiesterase 5 Inhibition Heather N. Tinsley, Bernard D. Gary, Jose Thaiparambil, Cancer Prevention Research Chemoprevention StrategyGastrointestinal PharmacologyCellular PharmacologyPharmacotherapyImmunotherapeutics	2010	91
A Novel Sulindac Derivative that Potently Suppresses Colon Tumor Cell Growth by Inhibiting cGMP Phosphodiesterase and β-Catenin Transcriptional Activity Jason Whitt, Li Nan, Heather N. Tinsley, Cancer Prevention Research	2012	82

Page 1